Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles Pauling Semba currently holds 40,412 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Pauling Semba has been a net buyer of DMAC stock. They have purchased $50.0K and sold $0 worth of shares.
Charles Pauling Semba's most recent insider trade was on Jun 1, 2026, when they sold 40,412 shares at $0.00 per share.
Charles Pauling Semba serves as Executive at DiaMedica Therapeutics Inc. (DMAC). They have executed 5 insider transactions totaling $50.0K over their tenure at the company.
Charles Pauling Semba holds the position of Executive at DiaMedica Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Charles Pauling Semba has shown a buying trading pattern, with $50.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Charles Pauling Semba was on Jun 23, 2023, when they purchased $50.0K worth of DMAC shares. This transaction involved 12,787 shares at $3.91 per share.
Charles Pauling Semba currently owns 40,412 shares of DiaMedica Therapeutics Inc. (DMAC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles Pauling Semba's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles Pauling Semba has 5 Form 4 filings on record as an insider at DiaMedica Therapeutics Inc..
Set alerts for Charles Pauling Semba and 40,000+ other insiders.